Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur A Levin

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Oligonucleotides|January 25, 2005
Distribution and excretion of a phosphorothioate oligonucleotide in rats with experimentally induced renal injuryLilit Masarjian, Ann de Peyster, Arthur A Levin, et al.
Journal of Immunotoxicology|October 30, 2008
Assessment of the effects of ISIS 2302, an anti-sense inhibitor of human ICAM-1, on cellular and humoral immunity in miceScott P Henry, Arthur A Levin, Kimber White, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|December 24, 2004
Effects of human and murine antisense oligonucleotide inhibitors of ICAM-1 on reproductive performance, fetal development, and post-natal development in miceScott P Henry, Kevin H Denny, Mike V Templin, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|December 24, 2004
Effects of an antisense oligonucleotide inhibitor of human ICAM-1 on fetal development in rabbitsScott P Henry, Kevin H Denny, Mike V Templin, et al.
Analytical Biochemistry|April 24, 2002
Development of an ultrasensitive noncompetitive hybridization-ligation enzyme-linked immunosorbent assay for the determination of phosphorothioate oligodeoxynucleotide in plasmaRosie Z Yu, Brenda Baker, Alfred Chappell, et al.
Archives of Internal Medicine|October 13, 2006
The FDA and drug safety: a proposal for sweeping changesCurt D Furberg, Arthur A Levin, Peter A Gross, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|February 24, 2006
Maternal and fetal distribution of a phosphorothioate oligonucleotide in rats after intravenous infusionNicole V Soucy, Jason P Riley, Michael V Templin, et al.
Journal of Pharmaceutical Sciences|December 4, 2003
Tissue disposition of 2'-O-(2-methoxy) ethyl modified antisense oligonucleotides in monkeysRosie Z Yu, Richard S Geary, David K Monteith, et al.
Toxicology|June 20, 2012
Renal uptake and tolerability of a 2'-O-methoxyethyl modified antisense oligonucleotide (ISIS 113715) in monkeyScott P Henry, Mark Johnson, Thomas A Zanardi, et al.
The American Journal of Pathology|June 28, 2011
Restoring dystrophin expression in duchenne muscular dystrophy muscle progress in exon skipping and stop codon read throughEric P Hoffman, Abby Bronson, Arthur A Levin, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Oligonucleotides|January 25, 2005
Distribution and excretion of a phosphorothioate oligonucleotide in rats with experimentally induced renal injuryLilit Masarjian, Ann de Peyster, Arthur A Levin, et al.
Journal of Immunotoxicology|October 30, 2008
Assessment of the effects of ISIS 2302, an anti-sense inhibitor of human ICAM-1, on cellular and humoral immunity in miceScott P Henry, Arthur A Levin, Kimber White, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|December 24, 2004
Effects of human and murine antisense oligonucleotide inhibitors of ICAM-1 on reproductive performance, fetal development, and post-natal development in miceScott P Henry, Kevin H Denny, Mike V Templin, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|December 24, 2004
Effects of an antisense oligonucleotide inhibitor of human ICAM-1 on fetal development in rabbitsScott P Henry, Kevin H Denny, Mike V Templin, et al.
Analytical Biochemistry|April 24, 2002
Development of an ultrasensitive noncompetitive hybridization-ligation enzyme-linked immunosorbent assay for the determination of phosphorothioate oligodeoxynucleotide in plasmaRosie Z Yu, Brenda Baker, Alfred Chappell, et al.
Archives of Internal Medicine|October 13, 2006
The FDA and drug safety: a proposal for sweeping changesCurt D Furberg, Arthur A Levin, Peter A Gross, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|February 24, 2006
Maternal and fetal distribution of a phosphorothioate oligonucleotide in rats after intravenous infusionNicole V Soucy, Jason P Riley, Michael V Templin, et al.
Journal of Pharmaceutical Sciences|December 4, 2003
Tissue disposition of 2'-O-(2-methoxy) ethyl modified antisense oligonucleotides in monkeysRosie Z Yu, Richard S Geary, David K Monteith, et al.
Toxicology|June 20, 2012
Renal uptake and tolerability of a 2'-O-methoxyethyl modified antisense oligonucleotide (ISIS 113715) in monkeyScott P Henry, Mark Johnson, Thomas A Zanardi, et al.
The American Journal of Pathology|June 28, 2011
Restoring dystrophin expression in duchenne muscular dystrophy muscle progress in exon skipping and stop codon read throughEric P Hoffman, Abby Bronson, Arthur A Levin, et al.
Pageof 4